Delivery Order SPE2DB20D2014-SPE2DB25FA33T
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$44K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,254.40 for the provision of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract has an ultimate completion date of November 16, 2023 and is a Firm Fixed Price arrangement. This award is a part of AmerisourceBergen's broader Indefinite Delivery Contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,922.74 firm fixed price delivery order is for the supply of valsartan-HCTZ 320-25 mg tablets. The contract has a completion date of June 17, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $22,603.51, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 6, 2025. The contract is not designated with any set-aside requirements, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.58, is for the supply of 4567790861 VALSARTAN-HCTZ 160-12.5 MG TAB 90S, a cardiovascular medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is April 4, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,912.99, is for the delivery of 4567626817 VALSARTAN-HCTZ 320-25 MG TAB 90S. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.42, is for the delivery of VALSARTAN-HCTZ 320-25 MG TAB 90S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of April 2, 2025. The contract is not set aside for any specific business type. AmerisourceBergen...
This federal contract award, valued at $4,296.28, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA), is a delivery order that provides the federal government with Valsartan-HCTZ 320-25 mg tablets. The contract has a firm fixed price and an ultimate completion date of June 26, 2024. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award, valued at $42,885.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $4,870.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has a completion date of March 11, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,250.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...